|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease显示文摘The search for biomarkers that characterize specific aspects of inflammatory bowel disease(IBD), has received substantial interest in the past years and is moving forward rapidly with the help of modern technologies. Nevertheless, there is a direct demand to identify adequate biomarkers for predicting and evaluating therapeutic response to different therapies. In this subset, pharmacogenetics deserves more attention as part of the endeavor to provide personalized medicine. The ultimate goal in this area is the adjustment of medication for a patient's specific genetic background and thereby to improve drug efficacy and safety rates. The aim of the following review is to utilize the latest knowledge on immunopathogenesis of IBD and update the findings on the field of Immunology and Genetics, to evaluate the response to the different therapies. In the present article, more than 400 publications were reviewed but finally 287 included based on design, reproducibility(or expectancy to be reproducible and translationable into humans) or already measured in humans. A few testshave shown clinical applicability. Other, i.e., genetic associations for the different therapies in IBD have not yet shown consistent or robust results. In the close future it is anticipated that this, cellular and genetic material, as well as the determination of biomarkers will be implemented in an integrated molecular diagnostic and prognostic approach to manage IBD patients. | Emilio G Quetglas Zlatan Mujagic Simone Wigge Daniel Keszthelyi Sebastian Wachten Ad Masclee Walter Reinisch | 2015 | World Journal of Gastroenterology2015，21，44： | 3 |
| 2 | Tumor marker CA 15-3 in breast cancer patients显示文摘 | Fejzic H Mujagic S Azabagic S | 2015 | Acta Med Acad2015，44，1： | 1 |
| 3 | Wegener' s granuloma- tosis of the paranasal sinuses with orbital and central nervous system involvement diagnostic imaging 显示文摘 | Mujagic S Sarihodzic S Huseinagic H | 2011 | Acta Neurol Belg2011，111，： | 1 |
| 4 | Interleukin 13 expression in the primary breast cancer tumour tissue显示文摘 | Srabovici N Mujagic Z Mujanovic Mustedanagic J | 2011 | Biochem Med2011，21，2： | 1 |
| 5 | Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species- dependent 显示文摘 | Mujagic E Gianni-Barrera R Trani M | 2013 | Hum Gene Ther Methods2013，24，1： | 1 |
| 6 | Importance of serum prolactin determination in metastatic breast cancer patients显示文摘 | MUJAGIC Z MUJAGIC H | 2004 | Croat Med J2004，45，2： | 1 |
| 7 | Digital design and manufacturing of the Lingualcare bracket system 显示文摘 | Mujagic M Fauquet C Galletti C | 2005 | J Clin Orthod2005，39，6： | 1 |
| 8 | Interleukin 13 expression in the primary breast cancer tumour tissue显示文摘 | Srabovici N Mujagic Z Mujanovic-Mustedanagic J | 2011 | Biochem Med2011，21，2： | 1 |
| 9 | Facs-purified myoblasts producing controlled vegf levels induce safe and stable angiogenesis in chronic hind limb ischemia显示文摘 | Wolff T Mujagic E Gianni-Barrera R | | 0，，01： | 1 |
| 10 | Digital design and manufacturing of the Lingualeare bracket system 显示文摘 | Mujagic M Fauquet C Galletti C | 2005 | J Clin Orthod2005，39，6： | 1 |
| 11 | The relationship between circulating caroinocmbryonic antigen(CEA) levels and parameters of primary tumor and metastases in breast cancer patients显示文摘 | Mujagic z Mujagic H Pmjavorac B | 2004 | Med Arh2004，58，1： | 1 |
| 12 | Inter- leukin 13 expression in the primary breast cancer tumour tissue 显示文摘 | Srabovici N Mujagic Z Mujanovic-Mustedanagic J | 2011 | Biochem Med(Zagreb)2011，21，2： | 1 |
| 13 | Interleukin 18 expression in the primary breastcancer tu- mour tissue 显示文摘 | Srabovic N Mujagic Z Mujanovic-Mustedanagic J | 2011 | Med Glas Ljek Komore Zenicko-doboj Kantona2011，8，1： | 1 |
| 14 | The relationship be tween circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients显示文摘 | Mujagic H Prnjavorac B | 2004 | Med Arh2004，58，： | 1 |
| 15 | Digital design and manufacturing of the Lingualcare bracket system显示文摘 | Mujagic M Fauquet C Galletti C | 2005 | J Clin Orthod2005，39，6： | 1 |
| 16 | Digital design and manufacturing of the lingual care bracket system显示文摘 | Mujagic M Fauquet C Galletti C | | 0，，06： | 1 |
| 17 | Use of aminoterminal pro-B type natriuretic peptide as the parameter for long term monitoring of water overload in patient with chronic kidney diseases显示文摘 | Prnjavorac B Mujagic Z Abduzaimovic K | 2011 | Med Glas Ljek komore Zenicko-doboj kantona2011，8，1： | 1 |
| 18 | Alterations in serotonin metabolism in the irritable bowel syndrome显示文摘 | A. Y. Thijssen Z. Mujagic D. M. A. E. Jonkers S. Ludidi D. Keszthelyi M. A. Hesselink C. H. M. Clemens J. M. Conchillo J. W. Kruimel A. A. M. Masclee | 2016 | Aliment Pharmacol Ther2016，，2： | 1 |
| 19 | Wegener's granulomatosis of the paranasal sinuses with orbital and central nervous system involvement-diagnostic imaging 显示文摘 | Mujagic S Sarihodzic S Huseinagic H | 2011 | Acta Neurol Belg2011，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员